Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Concurrent chemoradiotherapy (CRT) with blockade of the PD-1 pathway may enhance immune-mediated tumor control through increased phagocytosis, cell death, and antigen presentation. The NiCOL phase 1 trial (NCT03298893) is designed to determine the safety/tolerance profile and the recommended phase-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Manuel, Vanoni, Giulia, Loap, Pierre, Dubot, Coraline, Timperi, Eleonora, Minsat, Mathieu, Bazire, Louis, Durdux, Catherine, Fourchotte, Virginie, Laas, Enora, Pouget, Nicolas, Castel-Ajgal, Zahra, Marret, Gregoire, Lesage, Laetitia, Meseure, Didier, Vincent-Salomon, Anne, Lecompte, Lolita, Servant, Nicolas, Vacher, Sophie, Bieche, Ivan, Malhaire, Caroline, Huchet, Virginie, Champion, Laurence, Kamal, Maud, Amigorena, Sebastian, Lantz, Olivier, Chevrier, Marion, Romano, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287640/
https://www.ncbi.nlm.nih.gov/pubmed/37349318
http://dx.doi.org/10.1038/s41467-023-39383-8

Ejemplares similares

Ejemplares similares